International Journal of Mathematics Trends and Technology
Volume 31 | Number 1 | Year 2016 | Article Id. IJMTT-V31P508 | DOI : https://doi.org/10.14445/22315373/IJMTT-V31P508
The mean and variance of time between biological organ system due to some factors related disease or dysfunctions are obtained by generalized. This model suggests that a person unable to balance the body conditions due to the environmental factors which are the effects of human health conditions. The cell population takes into account the cell–cell heterogeneity of the progression rate across cell cycle phase within the tumour, and also allows for a non constant DNA synthesis and parabolic DNA synthesis rate across S phase. Sequential DNA– BrdUrd distributions were obtained in vivo from a human ovarian carcinoma transplanted in mice. In this paper the mean and variance of time between failures of biological organ System. We use the mathematical model by defining the space a complete probability spaces and be a measurable space. For any set , has an exponential distribution with parameter and it is used the suitable assumption and the corresponding results are obtained. If the tumour cell levels exceed a threshold level, the organ system reaches threat state or dysfunction state.
[1] Abdel-Hameed,M.S., (1984). Life distribution properties of devices subject to a levy wear success, Math Res.9(3) (1984).
[2] Abdel – Hameed,M.S and Proschan F., (1975). Shock models with underlying birth success, J Appl.Prob.12,18-28.
[3] Alessandro Bertuzzi., Mario Faretta., (2002). Kinetic heterogeneity of an experimental tumour revealed by BrdUrd incorporation and mathematical modelling. Bulletin of Mathematical Biology 64, 355–384.
[4] Baisch, H. and U. Otto (1993). Intratumoral heterogeneity of S phase transition in solid tumours determined by bromodeoxyuridine labelling and flow cytometry. Cell Prolif. 26, 439– 448.
[5] Baisch, H., U. Otto, U. Hatje and H. Fack (1995). Heterogeneous cell kinetics in tumors analyzed with a simulation model for bromodeoxyuridine single and multiple labeling. Cytometry21,52–61.
[6] Bergers, E., P. J. van Diest and J. P. Baak (1996). Tumour heterogeneity of DNA cell cycle variables in breast cancer measured by flow cytometry. J. Clin. Pathol. 49, 931–937.
[7] Bertuzzi, A., N. Del Grosso, A. Gandolfi, C. Sinisgalli and G. Starace (1995a). Cell cycle analysis by the relative movement approach: effect of variability across S-phase of DNA synthesis rate. Cell Prolif. 28, 107–120.
[8] Cappella, P., D. Tomasoni, M. Faretta, M. Lupi, F. Montalenti, F. Banzato, M. D’Incalci and P. Ubezio (2001). Cell cycle effects of gemcitabine. Int. J. Cancer 93, 401–408.
[9] Carlton, J. C., N. H. A. Terry and R. A. White (1991). Measuring potential doubling times of murine tumors using flow cytometry. Cytometry 12, 645–650.
[10] Chiorino, G., J. A. J. Metz, D. Tomasoni and P. Ubezio (2001). Desynchronization rate in cell populations: mathematical modeling and experimental data. J. Theor. Biol. 208, 185–199.
[11] Dolbeare, F. (1995). Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part I: historical perspectives, histochemical methods and cell kinetics. Histochem. J. 27, 339–369.
[12] Dolbeare, F., H. Gratzner, M. G. Pallavicini and J. W. Gray (1983). Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 80, 5573–5577.
[13] Gratzner, H. G. (1982). Monoclonal antibody to 5-bromo- and 5-iododeoxyuridine: a new reagent for detection of DNA replication. Science 218, 474–475.
[14]. Jayakumar, S., Karpagam, S., (2012). Mathematical model for the spread of infectious disease in varying environments JP journal of App. Mat Vol. 4 ,1-7.
[15] Kallinowski, F., K. H. Schlenger, S. Runkel, M. Kloes, M. Stohrer, P. Okunieff and P.Vaupel (1989). Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts. Cancer Res. 49, 3759–3764.
[16] Massazza, G., A. Tomasoni, A. Lucchini, P. Allavena, E. Erba, N. Colombo, A. Mantovani, M. D’Incalci, C. Mangioni and R. Giavazzi (1989). Intraperitoneal and subcutaneous xenograft of human ovarian carcinoma in nude mice and their potential in experimental therapy. Int. J. Cancer 44, 494–500.
[17] Mohamed Abdel –Hameed, Life distribution properties of devices subject to a pure jump Damage Process, J.Appl.Prob-21,816-825 (1984)
[18] Sisken, J. E. and L. Morasca (1965). Intrapopulation kinetics of the mitotic cycle. J. Cell Biol. 25, 179–189.
[19] Steel, G. G. (1977). Growth Kinetics of Tumours: Cell Population Kinetics in Relation to the Growth and Treatment of Cancer, Oxford: Clarendon Press.
[20] Terry, M. H. A., C. G. Milross, N. Patel, K. A. Mason, R. A. White and L. Milas (1997). The effect of paclitaxel on the cell cycle kinetics of a murine mammary adenocarcinoma in vivo. Breast J. 3, 99–105.
[21] Ubezio, P. (1990). Cell cycle simulation for flow cytometry. Comp. Meth. Programs Biomed. 31, 255–266.
[22] Ubezio, P., S. Filippeschi and L. Spinelli (1991). Method for kinetic analysis of druginduced cell cycle perturbations. Cytometry 12, 119– 126.
[23] White, R. A. (1989). Computing multiple cell kinetic properties from a single time point. J. Theor. Biol. 141, 429–446.
[24] White, R. A. and M. L. Meistrich (1986). A comment on ‘A method to measure the duration of DNA synthesis and the potential doubling time from a single sample’. Cytometry 7, 486–490.
[25] White, R. A., M. L. Meistrich, A. Pollack and N. H. Terry (2000). Simultaneous estimation of TG2+M, TS, and Tpot using single sample dynamic tumor data from bivariate DNAthymidine analogue cytometry. Cytometry 41, 1–8.
[26] White, R. A., N. H. A. Terry and M. L. Meistrich (1990). New methods for calculating kinetic properties of cells in vitro using pulse labelling with bromodeoxyuridine. Cell Tissue Kinet. 23, 561–573.
[27] Yanagisawa, M., F. Dolbeare, T. Todoroki and J.W. Gray (1985). Cell cycle analysis using numerical simulation of bivariate DNA/Bromodeoxyuridine distributions. Cytometry 6, 550–562.
S. Karpagam, S. Jayakumar, "Mathematical model for Kinetic Heterogeneity of an Experimental Tumour Revealed by BrdUrd Incorporation," International Journal of Mathematics Trends and Technology (IJMTT), vol. 31, no. 1, pp. 34-38, 2016. Crossref, https://doi.org/10.14445/22315373/IJMTT-V31P508
PDF 
Abstract 
Keywords 
References 
Citation